Home page > Quality health systems and services | Medicines, health technology and health information


Please find all related articles below.

Commissioner Dalli outlines strategy for pharmaceutical sector

European Commissioner for Health and Consumer Policy, John Dalli, attended the 53rd Annual Meeting of the European Association of Full Line Wholesalers and outlined his health strategy for the Pharmaceutical Sector. Commissioner Dalli started out his speech with the challenges that EU health systems are facing today. Among others, he mentioned increasing healthcare expenditures due to ageing, multiple morbidities and chronic diseases, higher patient expectations, and technological (...)

The European Medicines Agency launches website on new European database of suspected adverse drug reaction

The European Medicines Agency (EMA) launched last May 31st the new European database of suspected adverse drug reaction reports website. The launch of this website is a positive first step in the implementation of the EudraVigilance access policy. The information carried on the site relates to approximately 650 medicines and active substances authorised through the centralised procedure. Within a year the EMA aims to additionally publish suspected side-effect reports for common drug (...)

Counterfeit medicines: What role for patients?

The Council of Europe’s eTACT project project is a collaborative system to better, in support of the Falsified Medicines Directive, secure the legal supply-chain of medicinal products from manufacturers to consumers. It proposes a flexible structure that could provide patients with a role in the identification of falsified medicines by using new technology to check the authenticity of products. However, instead of ’empowering’ patients and enhancing trust, the effects (...)

Getting drugs online: Illegal online pharmacies target young people

The International Narcotics Control Board published its Annual report 2011 in which it warns that an increasing number of illegal Internet pharmacies in the world target young audiences via social media - increasing risks of long-term addiction to medicines. The International Narcotics Control Board has chosen to highlight this new trend as national and international regulations find it difficult to address the issue so far. The Annual report 2011 points out that illicit drugs or (...)

How does European trade policy impact on public health?

Belgian organisation "Action Platform for Health and Solidarity" organised a conference in the Belgian Senate to debate the impact of European trade policy on public health from a global perspective. This intervenes in a context in which the free trade agreements the European Union is negotiating with countries in the South can threaten the right to health. The Belgian Parliamentary Committee on Foreign Affairs and Defence organised a conference on the impact of European trade policy on (...)

EU-India Free Trade Agreement may hinder access to essential medicines

The EU is about to conclude its Free Trade Agreement negociations with India. Current negotiations threaten the pivotal role India plays in supplying affordable generic versions of drugs throughout the developing world. EPHA provides more information on the issues at stake. India`s role in access to affordable generic medicines In recent years, India has become "the pharmacy of the developing world". Ninety-two percent of people living with HIV on treatment in low- and middle-income (...)

Health Priorities of the French Presidency, July 2008

The French Presidency of the EU will run from 1 July 2008 until 31 December 2008. On Health issues, the French Presidency has made some priorities: 1. Health Security: Anti-microbial resistance and mandate for the ECDC, Health Security Committee 2. Mental Health: Alzheimer 3. Tobacco: preparation of the EU towards the Conference of Parties, FCTC in November 2008. 4. Health Strategy 5. Directive on the application of Patient Rights on Cross border Health care: please find more (...)